Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery

Summary

Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit

Timeline

Start

2003-01

Primary completion

2008-12

Completion

2008-12

Outcome

Outcome not reported

Stopped: “The study was stopped due to difficulties in including patients”

Drugs

Indications